This page shows you the latest news items in this category. This is page number 19.

Total 3342 results found since Jan 2013.

A comprehensive list of 2023 tech layoffs
Last year’s tech-wide reckoning continues. In 2023, layoffs have yet again cost tens of thousands of tech workers their jobs; this time, the workforce reductions have been driven by the biggest names in tech like Google, Amazon, Microsoft, Yahoo and Zoom. Startups, too, have announced cuts across…#google #amazon #yahoo #twilioannounced #githubannounced #fortune #github #yahooannounced #gitlabannounced #affirmannounced
Source: Reuters: Health - February 16, 2023 Category: Consumer Health News Source Type: news

Jumia laid off 20% of staff in Q4 2022 amid work to reduce losses by half this year
Jumia, as part of its streamlining efforts, reduced headcount by 60% in Dubai and “undertook overall headcount reductions that resulted in over 900 position terminations across its 11 markets, corresponding to a 20% headcount reduction.” This occurred in Q4 last year, according to the statement…#dubai #q4 #francisdufay #africa #jumia #african #nigeria #morocco #ivorycoast #algeria
Source: Reuters: Health - February 16, 2023 Category: Consumer Health News Source Type: news

Higher Bills Are Leading Americans to Delay Medical Care
Inflation and pressing household expenses are forcing some people to postpone health needs, an emerging trend that has health experts worried that conditions may only worsen.
Source: NYT Health - February 16, 2023 Category: Consumer Health News Authors: Reed Abelson Tags: Coronavirus (2019-nCoV) Health Insurance and Managed Care Layoffs and Job Reductions Medicaid Commonwealth Fund Source Type: news

Xerostomia may signal that liver disease 'has progressed' to cirrhosis in 50% of patients
Reductions in the flow rate of saliva may become increasingly apparent as alcohol-related liver disease advances.
Source: Daily Express - Health - February 16, 2023 Category: Consumer Health News Source Type: news

Magic Eden Undergoing Restructuring Process, Lays Off 22 Employees
Following a spree of layoffs across the crypto industry in 2022 – a microcosm of the tech industry at large, which also saw plenty of reductions last year – Magic Eden becomes the latest company to cut its headcount. Restructuring Partly Due to Solana Evolution Magic Eden, an NFT marketplace that…#magiceden #nft #solana #jacklu #healthcare #headspace #aptoslabs #origin #cryptopotato
Source: Reuters: Health - February 14, 2023 Category: Consumer Health News Source Type: news

Landmark Theatres Increases Footprint In LA: Arthouse Exhibitor Taking Over AMC ’s Sunset 5
Good news for the Los Angeles arthouse scene: Landmark Theatres is taking over AMC’s Sunset 5 at 8000 W Sunset Boulevard. The Cohen Media Group owned exhibitor will take over the venue in June. Until that time, the Sunset 5 will remain open and continued to be operated by AMC. The news comes in…#landmarktheatres #amc #8000wsunsetboulevard #mediagroup #landmark #picoblvd #google #oncelandmark #sunset5 #michaelfant
Source: Reuters: Health - February 14, 2023 Category: Consumer Health News Source Type: news

Janssen Data at ASCO GU Support Ambition to Transform Treatment of Prostate and Bladder Cancer Through Precision Medicine and Early Intervention
RARITAN, N.J., February 13, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced plans to present more than 20 abstracts featuring seven oncology therapies from its robust portfolio and pipeline at the annual American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, taking place in San Francisco on February 16-18. Building on more than a decade of leadership in the development of medicines for people diagnosed with GU cancers, Janssen will present data demonstrating its ambition to advance patient-centered treatment through precision medicine, real-world evidence a...
Source: Johnson and Johnson - February 13, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

In an Uncertain Job Market, How Can Companies Retain Workers?
Although some employees might decide to stick with their jobs when the market appears uncertain, work force reductions can, conversely, spur more quitting. Reports of layoffs have cast a shadow over the recent surge in quitting. Tech behemoths like Amazon and Meta and, most recently, Dell and…#amazon #meta #dell #blackrock #goldmansachs #mcdonalds #anthonyklotz #greatresignation #uslabordepartments #laszlobock
Source: Reuters: Health - February 13, 2023 Category: Consumer Health News Source Type: news

‘Dangerous procrastination’: 24 of world’s largest firms slack on climate pledge
The 2023 Corporate Climate Responsibility Monitor report says major companies’ current plans do not reflect the necessary urgency for emission reductions. Photo: Shutterstock
Source: Reuters: Health - February 13, 2023 Category: Consumer Health News Source Type: news

AMC Theatres shouldn ' t be charging more for the best seats
Nicole Kidman in an ad for AMC Theatres, which announced a new pricing model this week. AMC Theatres AMC Theatres announced this week that it would charge more for the best seats in its auditoriums. But that's not going to help the struggling theatrical industry. The company should be scaling down…#nicolekidman #amctheatres #amcstubsalist #newyorkcity #elijahwood #avatarwayofwater #cineworld #regalcinemas #amc #moffetnathanson
Source: Reuters: Health - February 11, 2023 Category: Consumer Health News Source Type: news

Medical Cannabis Tied to Lessening of Opioid Dosages
FRIDAY, Feb. 10, 2023 -- Among patients taking long-term opioid therapy, medical cannabis is associated with reductions in opioid dosages, according to a study published online Jan. 30 in JAMA Network Open. Trang Nguyen, M.D., Dr.P.H., from the New...
Source: Drugs.com - Pharma News - February 10, 2023 Category: Pharmaceuticals Source Type: news

New phase III data show Roche ’s Vabysmo rapidly improved vision and reduced retinal fluid in people with retinal vein occlusion (RVO)
Vabysmo met its primary endpoint in two clinical trials, BALATON and COMINO, showing non-inferior visual acuity gains compared toafliberceptMoreVabysmo patients showed an absence of blood vessel leakage in the retina compared toaflibercept in a pre-specified exploratory endpointIf approved, RVO would be the third indication forVabysmo in addition toneovascular or ‘wet’ age-related macular degeneration and diabetic macular edemaBasel, 10 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive new data from two global phase III studies, BALATON and COMINO, evaluating Vabysmo ® (faricimab) in macular ...
Source: Roche Media News - February 10, 2023 Category: Pharmaceuticals Source Type: news

Difelikefalin Improves Itch Intensity in Notalgia Paresthetica
THURSDAY, Feb. 9, 2023 -- Oral treatment with difelikefalin results in greater reductions in itch intensity scores than placebo among patients with notalgia paresthetica, but it does not improve secondary outcomes, according to a study published in...
Source: Drugs.com - Pharma News - February 9, 2023 Category: Pharmaceuticals Source Type: news

Severe, Atypical Skin Reactions With Amivantamab in NSCLC Severe, Atypical Skin Reactions With Amivantamab in NSCLC
Some of the cutaneous adverse events to amivantamab, which targets both EGFR and MET, can be severe and have atypical presentations, which led to dose reductions in five of six cases.MDedge News
Source: Medscape Hematology-Oncology Headlines - February 9, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news